Global variation in clinical profile, management, and post-discharge outcomes among patients hospitalized for worsening chronic heart failure: findings from the ASTRONAUT trial-Reference-Cited by-同舟云学术

Global variation in clinical profile, management, and post-discharge outcomes among patients hospitalized for worsening chronic heart failure: findings from the ASTRONAUT trial

Published:2015-04-30 Issue:6 Volume:17 Page:591-600
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Greene Stephen J.¹,Fonarow Gregg C.²,Solomon Scott D.³,Subacius Haris¹,Maggioni Aldo P.⁴,Böhm Michael⁵,Lewis Eldrin F.³,Zannad Faiez⁶,Gheorghiade Mihai¹,

Affiliation:

1. Center for Cardiovascular Innovation; Northwestern University Feinberg School of Medicine; Chicago IL USA

2. Ahmanson-UCLA Cardiomyopathy Center; University of California Los Angeles; Los Angeles CA USA

3. Cardiovascular Division; Brigham and Women's Hospital; Boston MA USA

4. Associazione Nazionale Medici Cardiologi Ospedalieri Research Center; Florence Italy

5. Klinik für Innere Medizin III; Universitätsklinikum des Saarlandes; Homburg Germany

6. Clinical Investigation Center; INSERM-CHU de Nancy Hôpital Jeanne d'Arc; Dommartin-les Toul Cedex France

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ejhf.280/fullpdf

Reference28 articles.

1. Heart disease and stroke statistics-2014 update: a report from the American Heart Association;Go;Circulation,2014

2. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure;Gheorghiade;JAMA,2006

3. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF);O'Connor;Am Heart J,2008

4. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial;Teerlink;Lancet,2013

5. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial;Konstam;JAMA,2007

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Geographical variation in patient characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction;European Journal of Heart Failure;2024-06-23

2. Regional Differences in the Epidemiology of Heart Failure;Korean Circulation Journal;2024

3. New onset heart failure with reduced ejection fraction management: single center, real-life Tunisian experience;The Egyptian Heart Journal;2023-11-07

4. Developing Clinical Risk Prediction Models for Worsening Heart Failure Events and Death by Left Ventricular Ejection Fraction;Journal of the American Heart Association;2023-10-03

5. Cost-Effectiveness of Intensive Versus Standard Blood Pressure Treatment in Older Patients With Hypertension in China;Hypertension;2022-11